Naive T cell subset removal

Naive T cell subset removal" is not a specific molecular entity; rather, it refers to the experimental or clinical depletion of naive T lymphocyte populations from the immune repertoire. Naive T cells are a subset of T lymphocytes that have exited the thymus but have not yet encountered antigen, and their removal can be achieved through cytotoxic drugs, irradiation, viral infection, or experimental cell sorting[5][3]. These cells are identified in immunology by markers such as CD45RA and CCR7[3]. The removal of naive T cells can significantly impact the diversity and adaptability of immune responses, leading to reduced capacity for new antigen recognition and increased immunosuppression[6]. In clinical research, this manipulation is used for studying immune reconstitution, transplantation tolerance, and autoimmunity, but it does not represent a druggable molecular target, receptor, or gene product[5][1][3].